文献速递骨质疏松与代谢性骨病创伤骨科

采用序贯解释性混合方法评估脆性骨折后启动骨质疏松治疗的治疗机会窗

Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures.
PubMed 文献 · Osteoporos Int · 2018-02-14

研究纳入1086名50岁以上近期脆性骨折患者,随机分配至标准 care、最小干预或强化干预组,另设专科组324例,随访48个月。结果显示12个月内启动骨质疏松治疗的比例在最小干预组为41.0%、强化干预组为54.3%、专科组为68.4%、标准 care组为18.9%,此后启动率急剧下降。患者和医生未将脆性骨折视为骨病标志是未治疗的主要原因。

要点

  • 脆性骨折后12个月内是启动骨质疏松治疗的最佳窗口,1年后机会窗已关闭。
  • 强化干预组12个月内启动治疗比例为54.3%,高于最小干预组的41.0%和标准 care组的18.9%。
  • 专科组12个月内启动治疗比例最高,达68.4%。

核心结论

  • 新发脆性骨折是启动骨质疏松治疗的理想机会,但1年后治疗机会窗已经关闭。

研究设计与样本

  • 研究纳入1086名50岁以上近期脆性骨折的男性和女性,分配至标准 care、最小干预或强化干预组,另设专科组324例,随访48个月,并进行定性分析。

主要发现

  • 最小干预组和强化干预组12个月内启动骨质疏松治疗的比例分别为41.0%和54.3%,专科组为68.4%,标准 care组为18.9%,此后启动率急剧下降。
  • 在4863患者年的随访中,新发脆性骨折发生率为每100患者年3.4例,初始主要或次要脆性骨折患者之间、对照组与干预组之间均无显著差异。
  • 患者和医生未能将脆性骨折识别为潜在骨病的标志是导致未治疗的最主要因素。

关键数值与推荐

  • 12个月内启动骨质疏松治疗比例:最小干预组41.0%,强化干预组54.3%,专科组68.4%,标准 care组18.9%。
  • 新发脆性骨折发生率:每100患者年3.4例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Interventions targeting patients with recent fragility fracture and their physician were most successful at initiating osteoporosis treatment during the first 12 months. This window of opportunity had already closed after 1 year. The reasons for declining or accepting the intensive intervention were explored in patients still untreated at 12 months. INTRODUCTION: A fragility fracture (FF) event identifies patients most likely to benefit from osteoporosis treatment. Nonetheless, most FF patients go untreated. Our objective was to determine how long an incident FF remains a strong incentive to initiate osteoporosis treatment. METHODS: A total of 1086 men and women over age 50 with a recent FF event were assigned to either standard care (SC), to minimal (MIN), or intensive (INT) interventions targeting patients and their family physician to initiate osteoporosis treatment. Inpatients with FF (mainly hip) evaluated by rheumatologists were also included in a specialized group (SPE; n = 324). At 1 year, untreated patients in both the SC and the MIN groups were offered an INT intervention. The cohort was followed through 48 months. A qualitative analysis of patient-centered decision-making associated with initiation of treatment was conducted. RESULTS: In MIN and INT groups, osteoporosis treatment was initiated in 41.0 and 54.3% of untreated patients by 12 months, respectively, compared to 68.4% in SPE and 18.9% in SC groups; initiation rates drastically dropped thereafter. Over 4863 patient-years of follow-up, the rates of new FF were 3.4 per 100 patient-years, without significant differences between patients with initial major or minor FF, nor between control or intervention groups. Failure by patients and physicians to recognize FF as a sign of underlying bone disease contributed the most to lack of treatment. CONCLUSION: While incident FFs are an ideal opportunity for starting osteoporosis treatment, 1 year later, the therapeutic window of opportunity has already closed.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Roux S, Gaboury I, Gionet-Landry N, et al. Using a sequential explanatory mixed method to evaluate the therapeutic window of opportunity for initiating osteoporosis treatment following fragility fractures. Osteoporos Int. 2018. PMID: 29445831. doi:10.1007/s00198-017-4374-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。